Although the content of the article(s) archived were correct at the time of writing, the accuracy of the information should not be relied upon, as it may have been subject to subsequent tax, legislative or event changes.
UK Chancellor Rachel Reeves will have breathed a sigh of relief last week, after she managed to deliver her Spring Statement without causing much of a market reaction.
Coming into the day, Reeves would have been encouraged by the news that UK inflation unexpectedly fell from 3% in January to 2.8% in February. Clothing prices, particularly women’s clothes, were the biggest driver for the fall, according to the Office for National Statistics (ONS).
Despite this, Reeves’ options for the Statement were somewhat boxed in by economic developments since her 2024 Budget, meaning spending cuts or tax rises were in order.
Ultimately, she chose spending cuts for now, though it remains to be seen whether this will be enough long term.
Describing the market reaction, Johnathan Owen, Portfolio Manager at TwentyFour Asset Managers, said: “Gilts began Spring Statement day in positive territory on Wednesday as they were buoyed by an encouraging UK inflation print, but the fairly muted gains reflected market caution around the spending adjustments later announced by Chancellor Rachel Reeves.
“We suspect the Bank of England will use its May 8 [Monetary Policy Committee] meeting as a window to push through another rate cut, but beyond that markets will need stronger evidence of labour market weakening before pricing in any more [interest rate] cuts for 2025. With growth faltering, fiscal headroom tight, and the risk of tariffs looming, the UK is at a crossroads.”
One statistic to note from the Spring Statement was that the Office for Business Responsibility downgraded the UK’s expected GDP growth from 2% to 1% for this year. This would put it slightly below 2024’s growth. At the end of last week, the ONS released its Q4 GDP statistics, which showed 0.1% growth between October and December, leaving the UK economy up 1.1% for the 2024.
Reacting to this deluge of economic information, markets were broadly flat, with the FTSE 100 up just 0.1% over the week.
Of course, the elephant in the room for all growth projections remains trade policy, specifically those related to the US.
President Donald Trump looks set to ramp up his use of tariffs on what he has termed Liberation Day, on Wednesday.
Currently, we don’t know exactly what will be announced; however, Trump is expected to announce some form of reciprocal tariffs. For the UK and Europe, a key question will be how Trump treats VAT when considering trade barriers. Emerging markets are currently considered vulnerable as well, as they tend to impose higher tariffs on imports.
While Liberation Day is garnering most of the attention, there were several key developments in the US last week. For example, Trump announced 25% tariffs for cars not built in the US, which sent a number of car manufacturer share prices down.
US markets have struggled with the President’s policy shift so far. Last week the Nasdaq dropped 2.4%, while the S&P 500 fell 1.5%.
While these tariffs will cause challenges, Martin Hennecke, Head of Asia & Middle East Investment Advisory, notes: “For all the tariff noise emanating from the US, we should take note that the country’s share of global trade represents only 11% at present, as China overtook the US as the world’s largest trading nation long ago, in 2013 to be precise. As long as the rest of the world sticks to more friendly tariff policies amongst each other there may be hope of potentially less of a Trump fallout than feared.
An example Hennecke points to are recent trilateral talks between Japan, China and Korea, aimed at deepening trade ties.
Tariffs are known to have an inflationary effect. Last week, the Bureau of Economic Analysis revealed US core personal consumption expenditures inflation increased to 2.8% in February, up from 2.7% in January, and above expectations.
With more tariffs likely to be announced in the coming days, the Federal Reserve is likely to face a headache when it next meets to discuss interest rates.
We insure our tangible assets – cars, the contents of our homes, even our pets – almost as a matter of course. But protecting yourself, your standard of living and your health can be far more valuable than protecting your material possessions.
Different types of protection insurance exist, depending on what, or whom, you need to protect, and for how long. The three most widely available are income protection, life assurance and critical illness protection.
Income protection pays a percentage of your income so you can continue to cover bills and outgoings, if you’re unable to work through illness. This could be particularly useful if you’re self-employed, where you have responsibility for your health and welfare, as well as your pension.
Life assurance pays out a lump sum on death. If the policy is written in trust, the pay-out will be free from inheritance tax. More importantly, for most people, this will help avoid delays during probate. Life assurance policies differ from life insurance, as they are designed to be whole life policies, whereas life insurance policies are fixed term, which means they are generally cheaper.
Critical illness cover pays out a lump sum if you suffer a serious illness such as cancer or a heart attack. The cover can be for a specific time period or for your whole life. Given that we are all living longer, a critical illness policy may be one of the most important for your future financial resilience.
Taking out life assurance or critical illness protection could be the most far-sighted and potentially life-changing pieces of financial planning you’ll ever do. Do speak to us if you’d like to discuss protection in greater detail.
The levels and bases of taxation, and reliefs from taxation, can change at any time and are generally dependent on individual circumstances.
Trusts are not regulated by the Financial Conduct Authority.
What were your thoughts on the investment market six months ago? And three months ago? Are they the same today?
In a market where narratives can shift rapidly, it can be hard to block out the noise. But flip-flopping between views isn’t the answer, says Joe Wiggins, Investment Research Director at SJP.
Past performance is not indicative of future performance.
The value of an investment with St. James's Place will be directly linked to the performance of the funds you select and the value can therefore go down as well as up. You may get back less than you invested.
The information contained is correct as at the date of the article. The information contained does not constitute investment advice and is not intended to state, indicate or imply that current or past results are indicative of future results or expectations. Where the opinions of third parties are offered, these may not necessarily reflect those of St. James's Place.
Source: London Stock Exchange Group plc and its group undertakings (collectively, the “LSE Group”). ©LSE Group 2025. FTSE Russell is a trading name of certain of the LSE Group companies.
“FTSE Russell®” is a trade mark of the relevant LSE Group companies and is used by any other LSE Group company under license. All rights in the FTSE Russell indexes or data vest in the relevant LSE Group company which owns the index or the data. Neither LSE Group nor its licensors accept any liability for any errors or omissions in the indexes or data and no party may rely on any indexes or data contained in this communication. No further distribution of data from the LSE Group is permitted without the relevant LSE Group company’s express written consent. The LSE Group does not promote, sponsor or endorse the content of this communication.
© S&P Dow Jones LLC 2025; all rights reserved
Source: MSCI. MSCI makes no express or implied warranties or representations and shall have no liability whatsoever with respect to any MSCI data contained herein. The MSCI data may not be further redistributed or used as a basis for other indices or any securities or financial products. This report is not approved, endorsed, reviewed or produced by MSCI. None of the MSCI data is intended to constitute investment advice or a recommendation to make (or refrain from making) any kind of investment decision and may not be relied on as such.
SJP Approved 31/03/2025